Preclinical evaluation of novel 177Lu-labeled fibroblast activation protein inhibitor with albumin binder for radioligand therapy

Annals of Nuclear Medicine 2026

View at publisher
Authors: Kosuke Saito, Hiroyuki Watanabe, Kazuma Nakashima, Shohei Tsuchihashi, Yusuke Chiba, Kazuyuki Hashimoto, Shunsuke Fujino, Yukimasa Kawauchi, Hideya Saeki, Naoki Takashima, Masako Kawabata, Masahiro Ono
DOI: 10.1007/s12149-026-02167-3
Cited by: 2
References: 31

Fields of Study & Subjects

Peptidase Inhibition and Analysis Orthopedic Infections and Treatments Radiopharmaceutical Chemistry and Applications

Publication details

Journal / source
Annals of Nuclear Medicine
Publisher
Springer Science and Business Media LLC
Volume
40
Issue
6
Pages
667–675
Publication date
7 February 2026
Language
EN